Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
LAVAL, Que. – Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a friendly deal to acquire Solta Medical, Inc. a California-based company that makes medical devices used in cosmetic surgery procedures.
The Montreal-area company’s offer of US$2.92 per share for all of Solta’s stock is valued at US$250 million, a 40 per cent premium to Friday’s closing price on Nasdaq.
Solta’s board of directors supports offer, which requires that Valeant gets at least a majority of Solta’s shares.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.